[
    [
        {
            "time": "2019-02-10",
            "original_text": "【医药】江琦、王超（研究助理）：2月月报：信心正逐步恢复、Q1建议关注创新药、原料药和商业板块",
            "features": {
                "keywords": [
                    "医药",
                    "信心恢复",
                    "创新药",
                    "原料药",
                    "商业板块"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "创新药",
                    "原料药",
                    "商业板块"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药】江琦、王超（研究助理）：2月月报：信心正逐步恢复、Q1建议关注创新药、原料药和商业板块",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]